Who Buys Primaquine from India — 160 Importers Behind a $1.7M Market
India's primaquine import market is served by 160 active buyers who collectively imported $1.7M across 445 shipments. BORNEO PACIFIC PHARMACEUTICALS LTD (PAPUA NEW GUINEA) leads with a 13.4% market share, followed by UNITED NATIONS DEVELOPMENT PROGRAM and BORNEO PACIFIC PHARMACEUTICALS LTD,. The top 5 buyers together control 27.8% of total import value, reflecting a moderately competitive buyer landscape.
Top Primaquine Importers — Ranked by Import Value
BORNEO PACIFIC PHARMACEUTICALS LTD (PAPUA NEW GUINEA) is the leading primaquine importer from India, holding a 13.4% share of the $1.7M market across 445 shipments from 160 buyers. The top 5 buyers — BORNEO PACIFIC PHARMACEUTICALS LTD (PAPUA NEW GUINEA), UNITED NATIONS DEVELOPMENT PROGRAM (VENEZUELA), BORNEO PACIFIC PHARMACEUTICALS LTD, (PAPUA NEW GUINEA), KAANA AUSTRALIA PTY LTD (PAPUA NEW GUINEA), DALAL PHARMA CO (SOMALIA) — collectively control 27.8% of total import value.
Top Primaquine Buyers & Importers
Ranked by import value · 160 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | BORNEO PACIFIC PHARMACEUTICALS LTDPAPUA NEW GUINEA PRIMAQUINE PHOSPHATE TABLETS USP 13.2 MGPHARMACEUTICALS | $225.8K | 5 | 13.4% |
| 2 | UNITED NATIONS DEVELOPMENT PROGRAMVENEZUELA | $125.4K | 5 | 7.5% |
| 3 | BORNEO PACIFIC PHARMACEUTICALS LTD,PAPUA NEW GUINEA PRIMAQUINE PHOSPHATE TABLETS USP 13.2 MGPHARMACEUTICALS | $65.0K | 5 | 3.9% |
| 4 | KAANA AUSTRALIA PTY LTDPAPUA NEW GUINEA PRIMAQUINE PHOSPHATE TABLETS USP 13.2 MGPHARMACEUTICALS | $31.7K | 5 | 1.9% |
| 5 | DALAL PHARMA COSOMALIA PRIMA-15 TABLETS AS PER INVOICE | $19.2K | 5 | 1.1% |
| 6 | MINISTERIO DE SALUD Y DEPORTESBOLIVIA PRIMAQUINE PHOSPHATE TABLETS USP 5MG BAS | $17.1K | 5 | 1.0% |
| 7 | SECRETARIA DE SALUD DE HONDURASHONDURAS | $14.1K | 5 | 0.8% |
| 8 | INTERNATIONAL ORGANISATION FOR MIGYEMEN | $12.7K | 5 | 0.8% |
| 9 | NECTARO PHARMA PRIVATE LIMITEDPAPUA NEW GUINEA PRIMAQUINE PHOSPHATE TABLETS USP 13.2 MGPHARMACEUTICALS | $9.5K | 5 | 0.6% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Primaquine — and from which countries?
Flow of Primaquine exports from India: each country's share and the named importers behind the numbers
Primaquine — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Pakistan
Pakistan emerges as the first largest importing country, achieving a total trade value of $474.3K through 0 shipments. This represents a market share of 28.2% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Pakistan demonstrates strong market positioning with an average shipment value of $474.3K, indicating premium pricing strategy compared to the market average of $3.8K.
Pakistan is a key market for Primaquine imports, representing 28.2% of total trade value.
2Papua New Guinea
Papua New Guinea emerges as the second largest importing country, achieving a total trade value of $435.1K through 15 shipments. This represents a market share of 25.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Papua New Guinea has a diverse importer base, with their top importers including:
• BORNEO PACIFIC PHARMACEUTICALS LTD - $225.8K (51.9% of country's total business)
• BORNEO PACIFIC PHARMACEUTICALS LTD, - $65.0K (14.9% of country's total business)
• KAANA AUSTRALIA PTY LTD - $31.7K (7.3% of country's total business)
• NECTARO PHARMA PRIVATE LIMITED - $9.5K (2.2% of country's total business)
Key Insight: Papua New Guinea demonstrates strong market positioning with an average shipment value of $29.0K, indicating premium pricing strategy compared to the market average of $3.8K.
Papua New Guinea is a key market for Primaquine imports, representing 25.9% of total trade value.
3Somalia
Somalia emerges as the third largest importing country, achieving a total trade value of $276.8K through 2 shipments. This represents a market share of 16.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Somalia has a diverse importer base, with their top importers including:
• DALAL PHARMA CO - $19.2K (6.9% of country's total business)
Key Insight: Somalia demonstrates strong market positioning with an average shipment value of $138.4K, indicating premium pricing strategy compared to the market average of $3.8K.
Somalia is a key market for Primaquine imports, representing 16.5% of total trade value.
4Venezuela
Venezuela emerges as the fourth largest importing country, achieving a total trade value of $125.4K through 6 shipments. This represents a market share of 7.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Venezuela has a diverse importer base, with their top importers including:
• UNITED NATIONS DEVELOPMENT PROGRAM - $125.4K (100.0% of country's total business)
Key Insight: Venezuela demonstrates strong market positioning with an average shipment value of $20.9K, indicating premium pricing strategy compared to the market average of $3.8K.
Venezuela is a key market for Primaquine imports, representing 7.5% of total trade value.
5Solomon Islands
Solomon Islands emerges as the fifth largest importing country, achieving a total trade value of $113.0K through 0 shipments. This represents a market share of 6.7% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Solomon Islands demonstrates strong market positioning with an average shipment value of $113.0K, indicating premium pricing strategy compared to the market average of $3.8K.
Solomon Islands is a key market for Primaquine imports, representing 6.7% of total trade value.
Buyer Segment Analysis
TransData Nexus Primaquine buyer market intelligence
1Buyer Segment Analysis
Primaquine exports from India between 2022 and 2026 amounted to $1.7 million across 445 shipments, involving 116 exporters and 160 buyers in 64 countries. The repeat buyer rate stood at 35.0%. The top 10 buyers accounted for a significant portion of these exports.
Buyer Segments:
1. Distributors:
Distributors typically procure large quantities to supply regional markets, maintaining consistent order patterns to meet ongoing demand.
2. Government Procurement:
These entities procure medicines through tenders, often in bulk, to support national health programs. Their purchasing patterns are influenced by budget cycles and public health needs.
3. Hospital Groups:
Hospital groups purchase pharmaceuticals to meet patient needs, with order volumes varying based on patient intake and treatment protocols.
Country-Specific Import Regulations
TransData Nexus Primaquine buyer market intelligence
1Country-Specific Import Regulations
1. Pakistan:
2. Papua New Guinea:
3. Somalia:
4. Venezuela:
5. Solomon Islands:
Demand Drivers & Market Opportunity
TransData Nexus Primaquine buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Primaquine is primarily driven by its role in treating Plasmodium vivax malaria, prevalent in regions like Papua New Guinea, Somalia, and Venezuela. According to the World Health Organization (WHO), in 2024, there were approximately 6.5 million cases of P. vivax malaria globally, underscoring the need for effective treatment options.
Government healthcare programs and international organizations significantly influence procurement patterns. Many countries include Primaquine in their national treatment guidelines and essential medicines lists, aligning with the WHO's Essential Medicines List. Tender-based purchasing is common, with entities like the United Nations Development Program facilitating bulk procurement to ensure consistent supply and cost-effectiveness. The presence of 160 buyers across 64 countries indicates a broad and sustained market for Primaquine, presenting opportunities for suppliers to engage with diverse procurement channels.
Common Questions — Primaquine Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest primaquine buyer importing from India?
Based on import volume and value, BORNEO PACIFIC PHARMACEUTICALS LTD (PAPUA NEW GUINEA) leads with $225.8K in imports and a 13.4% market share — the highest of any single primaquine importer. UNITED NATIONS DEVELOPMENT PROGRAM (VENEZUELA) and BORNEO PACIFIC PHARMACEUTICALS LTD, (PAPUA NEW GUINEA) are the next largest buyers.
QHow many companies buy primaquine from India?
There are 160 active primaquine buyers importing from India, with a combined market of $1.7M across 445 shipments to 64 countries. The top 5 buyers hold 27.8% of total import value, while the remaining 155 buyers handle the other 72.2%.
QWhich countries import the most primaquine from India?
The top importing countries for primaquine from India are Pakistan (28.2%), Papua New Guinea (25.9%), Somalia (16.5%), Venezuela (7.5%), Solomon Islands (6.7%). These markets represent the largest demand centres for Indian pharmaceutical exports of primaquine, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for primaquine from India?
The average import transaction value for primaquine from India is $3.8K, with an average unit price of $3.37 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Primaquine buyer market intelligence
1Buyer Segment Analysis
Primaquine exports from India between 2022 and 2026 amounted to $1.7 million across 445 shipments, involving 116 exporters and 160 buyers in 64 countries. The repeat buyer rate stood at 35.0%. The top 10 buyers accounted for a significant portion of these exports.
Buyer Segments:
1. Distributors:
Distributors typically procure large quantities to supply regional markets, maintaining consistent order patterns to meet ongoing demand.
2. Government Procurement:
These entities procure medicines through tenders, often in bulk, to support national health programs. Their purchasing patterns are influenced by budget cycles and public health needs.
3. Hospital Groups:
Hospital groups purchase pharmaceuticals to meet patient needs, with order volumes varying based on patient intake and treatment protocols.
Country-Specific Import Regulations
TransData Nexus Primaquine buyer market intelligence
1Country-Specific Import Regulations
1. Pakistan:
2. Papua New Guinea:
3. Somalia:
4. Venezuela:
5. Solomon Islands:
Demand Drivers & Market Opportunity
TransData Nexus Primaquine buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Primaquine is primarily driven by its role in treating Plasmodium vivax malaria, prevalent in regions like Papua New Guinea, Somalia, and Venezuela. According to the World Health Organization (WHO), in 2024, there were approximately 6.5 million cases of P. vivax malaria globally, underscoring the need for effective treatment options.
Government healthcare programs and international organizations significantly influence procurement patterns. Many countries include Primaquine in their national treatment guidelines and essential medicines lists, aligning with the WHO's Essential Medicines List. Tender-based purchasing is common, with entities like the United Nations Development Program facilitating bulk procurement to ensure consistent supply and cost-effectiveness. The presence of 160 buyers across 64 countries indicates a broad and sustained market for Primaquine, presenting opportunities for suppliers to engage with diverse procurement channels.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 160 global importers of Primaquine identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 445 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 64 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
445 Verified Shipments
160 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists